A R T I C L E S
Seyedsayamdost et al.
Table 2. RP-HPLC and MALDI-TOF MS Characterization of
Fmoc-succinimide, Sephadex G-25 resin, DNase I (10 units/µL), and
Triton X-100 were purchased from Sigma. BL21 (DE3) RIL Codon+
competent cells were obtained from Stratagene. Calf-intestine alkaline
phosphatase (20 units/µL) was purchased from Roche. All amino acid
derivatives were purchased from Novabiochem, Fmoc-L-Leu-PEG-PS
resin and all other chemicals required for peptide synthesis were
obtained from Applied Biosystems. [2-14C]-CDP was purchased from
Moravek Biochemicals. E. coli thioredoxin (TR, SA of 40 units/mg)
and E. coli thioredoxin reductase (TRR, SA of 1800 units/mg) were
isolated as previously described.13
FnY-22mersa
MS of (tbuthio)-
MS of
RP-HPLC
Rt (min)
protected FnY-22mer
deprotected FnY-22mer
m/z [M −
H]- calcd (obs)
FnY-22mer
m/z [M
−
H]- calcd (obs)
Y-22mer
19
19
18.5
19
21.5
18
2548.6 (2548.2)
2584.6 (2585.2)
2584.6 (2584.0)
2602.6 (2601.9)
2602.6 (2601.5)
2642.6 (2641.4)b
2460.6 (2460.1)
2496.6 (2495.6)
2496.6 (2495.8)
2552.6 (2551.6)c
2552.6 (2551.6)c
2570.6 (2570.3)c
2,3-F2Y-22mer
3,5-F2Y-22mer
2,3,6-F3Y-22mer
2,3,5-F3Y-22mer
F4Y-22mer
Physical Measurements. 1H NMR spectra were recorded on a
Varian 300 MHz NMR spectrometer at the MIT Department of
Chemistry Instrumentation Facility. NMR samples were internally
referenced to tetramethylsilane. pH measurements were performed with
an Orion microelectrode. Absorption spectra were recorded on an
Agilent 8453 Diode Array spectrophotometer. EPR spectra were
recorded at 77 K on a Bruker ESP-300 X-band (9.4 GHz) spectrometer
equipped with an Oxford liquid helium cryostat.
a
See ref 21 for detailed description of HPLC and MALDI-TOF methods.
[M - 2H + Na]-. [M - 2H + K]-.
b
c
Table 3. Physical and Biochemical Characterization of
FnY356-R2s
ESI-MS
radical
contentb specific activity
(Y
/dimer) (nmol/min mg)c
maximal
yield
m/z [M
+
H]+
K
m for R1
M)
FnY356−R2
(mg)a
calcd (obs)
•
(µ
Synthesis of Fmoc-FnYs. Fmoc-FnYs were synthesized by the
method of Lapatsanis et al. with minor modifications.25 The tyrosine
analogue (700 µmol) was dissolved in 2.4 mL of 10% Na2CO3 and
mixed with Fmoc-succinimide (970 µmol) in 2.5 mL of dioxane at 4
°C. The reaction was warmed to room temperature and reacted for 20
min to 2 h (FnYs with higher fluorine substitution required longer
reaction times). The reaction was monitored via TLC using 10:1 CHCl3/
MeOH as the mobile phase. After completion, the reaction was
quenched with 25 mL of water and extracted twice with 10 mL of
EtOAc to remove Fmoc-succinimide. The pH was then lowered to 2-3
with 2 N HCl, and the solution was extracted with EtOAc (10×, 10
mL). The organic layer was washed with saturated NaCl (3×, 3 mL)
and water (2×, 3 mL) and finally dried over MgSO4. The solvent was
removed in vacuo, and the product was purified by silica gel
chromatography (16 g, 1.5 × 28 cm) using isocratic elution. The solvent
system, Rf, and the yield for each analogue are summarized in Table
S1 (Supporting Information).
Fmoc-L-3,5-F2Y: 1H NMR (300 MHz, CD3OD) δ ) 2.85 (dd, 1H,
Câ-H1, 9.7 Hz, 14.3 Hz), 3.12 (dd, 1H, Câ-H2, 5.7 Hz, 14.3 Hz), 4.2
(m, 3H, fluorenyl C-H and C-H2), 4.37 (dd, 1H, CR-H, 5.7 Hz, 10
Hz), 6.82 (m, 2H, PhOH C-H), 7.35 (dt, 4H, aromatic fluorenyl C-H,
7.6 Hz, 26.7 Hz), 7.62 (d, 2H, aromatic fluorenyl C-H, 7.5 Hz), 7.8
(d, 2H, aromatic fluorenyl C-H, 7.1 Hz).
Fmoc-L-2,3-F2Y: 1H NMR (300 MHz, CD3OD) δ ) 2.9 (dd, 1H,
Câ-H1, 9.6 Hz, 14.6 Hz), 3.23 (dd, 1H, Câ-H2, 4.8 Hz, 14.2 Hz),
4.24 (m, 3H, fluorenyl C-H and C-H2), 4.4 (dd, 1H, CR-H, 5 Hz,
9.7 Hz), 6.61 (m, 1H, PhOH C-H5), 6.82 (m, 1H, PhOH C-H6), 7.28
(m, 2H, aromatic fluorenyl C-H), 7.38 (t, 2H, aromatic fluorenyl C-H,
7.4 Hz), 7.6 (d, 2H, aromatic fluorenyl C-H, 7.4 Hz), 7.77 (d, 2H,
aromatic fluorenyl C-H, 7.4 Hz).
Fmoc-L-2,3,6-F3Y: 1H NMR (300 MHz, CD3OD) δ ) 3.02 (dd,
1H, Câ-H1, 9.3 Hz, 14 Hz), 3.2 (dd, 1H, Câ-H2, 5.7 Hz, 13.9 Hz),
4.2 (m, 3H, fluorenyl C-H and C-H2), 4.41 (dd, 1H, CR-H, 5.7 Hz,
9.4 Hz), 6.46 (m, 1H, PhOH C-H), 7.33 (dt, 4H, aromatic fluorenyl
C-H, 7.1 Hz, 26.7 Hz), 7.6 (d, 2H, aromatic fluorenyl C-H, 7 Hz),
7.78 (d, 2H, aromatic fluorenyl C-H, 9 Hz).
Fmoc-L-2,3,5-F3Y: 1H NMR (300 MHz, CD3OD) δ ) 2.9 (dd, 1H,
Câ-H1, 9.6 Hz, 13.5 Hz), 3.25 (dd, 1H, Câ-H2, 4.2 Hz, 13.8 Hz),
4.25 (m, 3H, fluorenyl C-H and C-H2), 4.43 (dd, 1H, CR-H, 4.7 Hz,
9.2 Hz), 6.82 (m, 1H, PhOH C-H), 7.32 (dt, 4H, aromatic fluorenyl
C-H, 7.2 Hz, 26.7 Hz), 7.58 (d, 2H, aromatic fluorenyl C-H, 7.2
Hz), 7.75 (d, 2H, aromatic fluorenyl C-H, 7.2 Hz).
Y-R2
2,3-F2Y356-R2
3,5-F2Y356-R2
14.3 43360 (43360)
15 43396 (43399)
20 43396 (43392)
0.34
450
370
450
365
95
0.55 ( 0.18
0.62 ( 0.11
ndd
0.33
0.31
0.42
0.41
0.42
1.1
2,3,5-F3Y356-R2 13 43414 (43410)
0.65 ( 0.15
2,3,6-F3Y356-R2 10.5 43414 (43413)
ndd
F4Y356-R2
10 43432 (43434)
30
1420
0.59 ( 0.2
0.55 ( 0.21
V
353G/ S354C-R2e
-
-
a
Amount recovered from incubation with 45 mg of MESNA-activated
b
R2. Measured by the dropline correction method and quantitative EPR
c
methods using recombinant wt R2 as standard. Activity of intein-generated
FnY356-R2s is normalized for radical content of Y-R2. nd ) not
determined. Made by recombinant methods.
d
e
9.3 Hz), 7.34 (dt, 4H, aromatic fluorenyl-H, 7.7 Hz, 27 Hz), 7.61 (d,
2H, aromatic fluorenyl-H, 7.2 Hz), 7.78 (d, 2H, aromatic fluorenyl-
H, 7.5 Hz).
Peptide Synthesis. The R2 C-terminal peptide CSFnYLVGQID-
SEVDTDDLSNFQL was synthesized by a combination of standard
solid-phase and solution-phase peptide synthesis methods as previously
described.21 The first 19 residues were added using a Pioneer Peptide
Synthesizer from Applied Biosystems. The remaining 3 amino acids
(positions 20-22 on the peptide) were coupled manually. The manual
coupling reaction of Fmoc-FnYs were carried out for 1 h, and a typical
reaction contained 4 equiv of Fmoc-FnY, 3.6 equiv of O-(7-azabenzo-
triazole-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU),
and 8 equiv of diisopropyl ethylamine (DIPEA) in DMF. The purified
peptides were characterized by RP-HPLC and MALDI-TOF MS. The
results are summarized in Table 2.
Semisynthesis of R2 and FnY356-R2s. Culture growth, ligation,
and protein purification were carried out as previously described21 with
minor modifications. After MESNA-mediated cleavage of R2(1-353)
from the chitin resin, excess MESNA was removed using a Sephadex
G-25 column (200 mL, 3 cm × 30 cm) equilibrated in cleavage buffer
(50 mM HEPES, pH 7.6, 500 mM NaCl). Furthermore, prior to
purification by MonoQ anion exchange chromatography, unbound
peptide was removed by concentration/dilution cycles using a YM-30
membrane. MonoQ purifications were performed under reducing
conditions with 1.5 mM DTT. Each FnY356-R2 was judged to be >95%
pure on the basis of SDS-PAGE analysis. Each R2 was further
characterized by ESI-MS, and the tyrosyl radical was quantitated by
UV-vis and EPR spectroscopic methods (Table 3).
Purification of R1 and Removal of Contaminating R2. R1 (SA
1900 nmol/min/mg) was purified as previously described.26 To reduce
the redox-active cysteines of R1 and the Y• of contaminating R2, which
copurifies with R1, R1 (∼40 µM) was incubated with 30 mM DTT
for 25 min at room temperature. Hydroxyurea, ATP, and CDP were
Fmoc-L-2,3,5,6-F4Y: 1H NMR (300 MHz, CD3OD) δ ) 3.06 (dd,
1H, Câ-H1, 9.2 Hz, 14.2 Hz), 3.26 (dd, 1H, Câ-H2, 5.4 Hz, 14.2 Hz),
4.23 (m, 3H, nonaromatic fluorenyl-H), 4.38 (dd, 1H, CR-H, 5.4 Hz,
(26) Salowe, S.; Bollinger, J. M., Jr.; Ator, M.; Stubbe, J.; McCraken, J.; Peisach,
(25) Lapatsanis, L.; Milias, G.; Froussios, K.; Kolovos, M. Synthesis 1983, 671.
J.; Samano, M. C.; Robins, M. J. Biochemistry 1993, 32, 12749.
9
1564 J. AM. CHEM. SOC. VOL. 128, NO. 5, 2006